| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 10 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.60M | $127.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2022 | Patel Snehal | CEO And CFO | Buy | 4,500 | $10.90 | $49,050.00 | +0.4% | |
| Jun 7, 2022 | Patel Snehal | CEO And CFO | Buy | 6,000 | $8.55 | $51,300.00 | +0.5% | |
| Jun 3, 2022 | Patel Snehal | CEO And CFO | Buy | 9,250 | $8.35 | $77,237.50 | +0.8% | |
| Jun 2, 2022 | Patel Snehal | CEO And CFO | Buy | 6,774 | $7.38 | $49,992.12 | +0.6% | |
| Apr 25, 2022 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1,000 | $16.25 | $16,250.00 | +1.1% | |
| Apr 21, 2022 | Patel Snehal | CEO And CFO | Buy | 6,000 | $16.09 | $96,540.00 | +0.5% | |
| Apr 19, 2022 | Patel Snehal | CEO And CFO | Buy | 6,000 | $16.74 | $100,440.00 | +0.5% | |
| Apr 19, 2022 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | $16.74 | $8,370.00 | +0.2% | |
| Feb 11, 2022 | Patel Snehal | CEO And CFO | Buy | 5,500 | $19.80 | $108,900.00 | +0.5% | |
| Feb 4, 2022 | Patel Snehal | CEO And CFO | Buy | 5,000 | $19.59 | $97,950.00 | +0.4% |